Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells.
Invasiveness of tumor cells is often determined by the profile of their expressed genes. To determine the gene expression differences between an invasive and a non-invasive human breast tumor cells, we selected BT-549 (invasive) and MDA-MB-468 (non-invasive) cells, and compared their transcriptomes by cDNA microarray analysis. Among the significant differences in gene expressions, notable are the up-regulation of cytokeratins 8 and 19, and down-regulation of metallothioneins 1G and IL in MDA-MB-468 cells. Since MDA-MB-468 cells do not express SLUG, a member of a small family of E2-box-binding zinc finger silencer proteins, we studied whether the cytokeratin gene overexpressions in these cells are due to the absence of SLUG. Inducible expression of SLUG in MDA-MB-468 cells inhibited the expressions of the cytokeratin 8 and 19 but not others as was revealed by microarray analysis. Similarly, siRNA knock down of SLUG in BT-549 cells increased the expressions of those cytokeratin mRNAs. SLUG levels in the cell regulated the function of cytokeratins 8 and 19 gene promoters. We conclude that the expressions of cytokeratins and metallothioneins may be associated with the differential invasive behaviors of these breast tumor cells and SLUG may have regulatory roles in this process.
Tripathi
Manish Kumar
MK
Division of Cancer Biology, Department of Basic Sciences, Meharry Medical College, Nashville, TN 37208, USA.
Misra
Smita
S
Chaudhuri
Gautam
G
D001943:Breast Neoplasms / Q000378:metabolism*; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007633:Keratins / Q000378:metabolism*; D012097:Repressor Proteins / Q000378:metabolism*; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000378:metabolism*
D012097:Repressor Proteins; C000604407:SNAI1 protein, human; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D007633:Keratins
Biochemistry. 1988 Nov 15;27(23):8509-15
3064814
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5658-62
2377606
Methods Enzymol. 1991;205:613-26
1779825
J Cell Physiol. 1992 Mar;150(3):534-44
1537883
Blood. 1992 Apr 1;79(7):1802-10
1313714
Nature. 1994 Feb 17;367(6464):654-7
8107851
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4452-6
7538671
Biol Chem Hoppe Seyler. 1995 Jul;376(7):441-6
7576242
Dev Biol. 1998 Jun 15;198(2):277-85
9659933
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
Mol Cell. 1999 Sep;4(3):343-52
10518215
Biochim Biophys Acta. 2004 Dec 6;1742(1-3):133-40
15590063
Biochem Biophys Res Commun. 2005 Mar 4;328(1):43-8
15670748
Radiat Res. 2000 Nov;154(5):590-9
11025655
Nat Cell Biol. 2000 Feb;2(2):84-9
10655587
Biochem Biophys Res Commun. 1999 Nov 19;265(2):285-90
10558858
Nat Cell Biol. 2000 Feb;2(2):76-83
10655586
Mol Cell Biol. 2004 Sep;24(17):7559-66
15314165
Cell. 2004 Aug 6;118(3):277-9
15294153
Cell. 2004 Jun 25;117(7):927-39
15210113
Exp Cell Res. 2004 Jul 1;297(1):11-26
15194421
Neoplasia. 2004 May-Jun;6(3):187-94
15153330
Cancer Sci. 2003 Oct;94(10):851-7
14556657
Clin Cancer Res. 2004 Apr 15;10(8):2670-4
15102669
J Pathol. 2004 Jun;203(2):661-71
15141381
Gene. 2000 Oct 17;257(1):1-12
11054563
Genomics. 2001 Jan 15;71(2):252-5
11161819
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
Breast Cancer Res Treat. 2001 Apr;66(3):265-72
11510698
J Biol Chem. 2002 Mar 8;277(10):8022-32
11777908
Cancer Res. 2002 Mar 15;62(6):1613-8
11912130
J Biol Chem. 2002 Mar 29;277(13):10767-74
11781324
Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
11994736
Genes Chromosomes Cancer. 2002 Jul;34(3):255-68
12007186
Nat Struct Biol. 2002 Jul;9(7):507-11
12055623
Curr Opin Genet Dev. 2002 Aug;12(4):423-9
12100887
EMBO J. 2002 Sep 16;21(18):4978-88
12234937
Cancer Cell. 2002 Oct;2(4):279-88
12398892
J Biol Chem. 2002 Dec 6;277(49):47263-9
12376545
J Cell Sci. 2003 May 15;116(Pt 10):1959-67
12668723
Oncogene. 2003 Jul 3;22(27):4205-11
12833143